Laura Joszt, MA

Laura Joszt headshot

Laura Joszt, MA, is the content director for The American Journal of Managed Care®. She has been with MJH Life Sciences since 2011.

Laura has an MA in business and economic reporting from New York University. You can connect with Laura on LinkedIn or Twitter.

Articles by Laura Joszt, MA

The use of orphan drugs for non-orphan diseases is driving up the cost of these already expensive medications. A new report from America’s Health Insurance Plans found that almost half of the utilization for 46 orphan drugs were used for non-orphan indications.

As the healthcare industry moves from volume to value, new healthcare delivery models are being tested and promoted, and CMS has put a lot of faith into the accountable care organization. So has Aledade.

The healthcare ecosystem can be a very complex place, and it’s important to remember that a patient sits at the center, explained David M. Cordani, president and CEO of Cigna Corp., during a general session on the second day of America’s Health Insurance Plans’ Institute & Expo.